scholarly article | Q13442814 |
P50 | author | Lijuan Zhu | Q94593359 |
P2093 | author name string | Aihua Wang | |
Mei Gao | |||
Zehua Li | |||
Xiaoyan Duan | |||
P2860 | cites work | A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? | Q24629627 |
The emergence of lncRNAs in cancer biology | Q27024237 | ||
High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer | Q36764934 | ||
Epidemiology of ovarian cancer: a review | Q37720438 | ||
Long noncoding RNAs: a potential novel class of cancer biomarkers | Q38466810 | ||
PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer | Q38803141 | ||
miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients | Q38876554 | ||
Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. | Q39320927 | ||
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer. | Q50063155 | ||
Noncoding RNA:RNA Regulatory Networks in Cancer. | Q52558382 | ||
Long non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to accelerate non-small cell lung cancer cells progression and metastasis. | Q52598743 | ||
Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway. | Q53040737 | ||
Ovarian cancer | Q54105461 | ||
Promotes Invasion through a 3'-Hairpin Structure and Associates with Prognosis in Glioblastoma | Q56928080 | ||
The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a | Q64075637 | ||
LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer | Q64086635 | ||
miR-128-3p inhibits glioma cell proliferation and differentiation by targeting NPTX1 through IRS-1/PI3K/AKT signaling pathway | Q64271446 | ||
The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling | Q89004313 | ||
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer | Q90587292 | ||
Cancer statistics, 2019 | Q90941571 | ||
MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1 | Q91944507 | ||
Integrative analysis of DNA methylation and gene expression profiles identifies MIR4435-2HG as an oncogenic lncRNA for glioma progression | Q92254444 | ||
LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis | Q92458060 | ||
Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines | Q92680530 | ||
Therapeutic effect of bevacizumab combined with paclitaxel and carboplatin on recurrent ovarian cancer | Q92693567 | ||
LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma | Q92762186 | ||
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 145 | |
P577 | publication date | 2020-05-01 | |
P1433 | published in | Cancer Cell International | Q1829859 |
P1476 | title | LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis | |
P478 | volume | 20 |
Search more.